Positron Emission Tomography in oncology: Present and future of PET and PET/CT

被引：35

作者：

Papathanassiou, Dimitri ^{[1
,4
]}

Bruna-Muraille, Claire ^{[1
,4
,6
]}

Liehn, Jean-Claude ^{[1
,4
]}

Nguyen, Tan Dat ^{[2
,4
,5
]}

Cure, Herve ^{[3
,4
]}

机构：

[1] Inst Jean Godinot, Nucl Med Serv, F-51056 Reims, France

[2] Inst Jean Godinot, Dept Radiotherapie, F-51056 Reims, France

[3] Inst Jean Godinot, Dept Med Oncol, F-51056 Reims, France

[4] Univ Reims, UFR Med, Reims, France

[5] Inst Jean Godinot, Radiat Dept, F-51056 Reims, France

[6] Univ Reims, Dept Biophys & Nucl Med, Reims, France

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2009年 / 72卷 / 03期

关键词：

PET; PET/CT; Imaging; Oncology; SQUAMOUS-CELL CARCINOMA; COLORECTAL LIVER METASTASES; STANDARDIZED UPTAKE VALUES; LYMPH-NODE METASTASES; SMALL ANIMAL PET; BODY FDG PET; F-18-FDG PET; LUNG-CANCER; DIAGNOSTIC-ACCURACY; COMPUTED-TOMOGRAPHY;

D O I：

10.1016/j.critrevonc.2008.10.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PET is a crucial technique in molecular imaging, allowing in vivo assessment and localization of pathological processes, thanks to its ability to detect very small amounts of radioactive molecules. This is of particular interest in oncology where abnormal metabolism or synthesis in tumor cells but also various tumor characteristics can be studied using this nuclear medicine technique. FDG is currently the most widely used tracer, nowadays essential in the management of various malignancies, with large applications in diagnosis, initial assessment, therapy monitoring, and recurrence detection. The combination of anatomical information provided by PET/CT further increased its interest. Beyond its spread use in daily practice, future applications of PET will involve other tracers than FDG and develop research applications in humans as well as in small animals. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：239 / 254

页数：16

共 147 条

[31]

Dearling JLJ, 2004, J NUCL MED, V45, P101

[32] Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls [J].

DeGaetano, Anna Maria ;

Calcagni, Maria Lucia ;

Rufini, Vittoria ;

Valenza, Venanzio ;

Giordano, Alessandro ;

Bonomo, Lorenzo .

ABDOMINAL IMAGING, 2009, 34 (03) :391-402

[33] PET and PET-CT for evaluation of colorectal carcinoma [J].

Delbeke, D ;

Martin, WH .

SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (03) :209-223

[34]

Delgado-Bolton RC, 2003, J NUCL MED, V44, P1301

[35] Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT [J].

Dirisamer, Albert ;

Schima, Wolfgang ;

Heinisch, Martin ;

Weber, Michael ;

Lehner, Hans Peter ;

Haller, Joerg ;

Langsteger, Werner .

EUROPEAN JOURNAL OF RADIOLOGY, 2009, 69 (03) :536-541

[36] In vivo imaging of oligonucleotides with nuclear tomography [J].

Duatti, A .

CURRENT DRUG TARGETS, 2004, 5 (08) :753-760

[37] 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer [J].

Eschmann, Susanne Martina ;

Friedel, Godehard ;

Paulsen, Frank ;

Reimold, Matthias ;

Hehr, Thomas ;

Budach, Wilfried ;

Langen, Heinz-Jakob ;

Bares, Roland .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) :463-471

[38] Gastrointestinal tract malignancies and positron emission tomography: An overview [J].

Esteves, FP ;

Schuster, DM ;

Halkar, RK .

SEMINARS IN NUCLEAR MEDICINE, 2006, 36 (02) :169-181

[39] Evolving role of positron emission tomography in breast cancer imaging [J].

Eubank, WB ;

Mankoff, DA .

SEMINARS IN NUCLEAR MEDICINE, 2005, 35 (02) :84-99

[40] 18F-fluoride positron emission tomography and positron emission tomography/computed tomography [J].

Even-Sapir, Einat ;

Mishani, Eyal ;

Flusser, Gideon ;

Metser, Ur .

SEMINARS IN NUCLEAR MEDICINE, 2007, 37 (06) :462-469

← 1 2 3 4 5 6 7 8 9 10 →